The increasing importance of inflammation in neurological disease

Current Opinion in Neurology

Volumn 20, Issue 3, 2007, Pages 331-333

  Bone, Ian ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; CORTICOSTEROID; CORTICOTROPIN; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN; CYTOKINE; GLUCOCORTICOID; HYDROXYCHLOROQUINE; INTERLEUKIN 4; METHOTREXATE; MINOCYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; SALAZOSULFAPYRIDINE; SALICYLIC ACID DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

COMPLEX REGIONAL PAIN SYNDROME; EDEMA; EDITORIAL; HUMAN; INFLAMMATION; MICROGLIA; NERVE FIBER; NERVE STIMULATION; NEUROGENIC INFLAMMATION; NEUROLOGIC DISEASE; PAIN; SENSORY NERVE CELL; SKIN TEMPERATURE; SPINAL CORD; T LYMPHOCYTE; VASODILATATION;

AUTONOMIC NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM; CYTOKINES; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; MICROGLIA; NERVOUS SYSTEM DISEASES; NEUROIMMUNOMODULATION; PERIPHERAL NERVOUS SYSTEM;

EID: 34248400811     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32813a3658     Document Type: Editorial

References (21)

1. Heidland A, Klassen A, Rutkowski P, Bahner U. The contribution of Rudolf Virchow to the concept of inflammation: what is still of importance? J Nephrol 2006; 19:S102-S109.
2. Bayliss WM. On the origin from the spinal cord of the vaso-dilator fibres of the hind-limb and the nature of these fibres. J Physiol (Lond) 1901; 26:173-209.
3. Bowden JJ, Garland AM, Baluk P, et al. Direct observations on Substance P-induced internalisation on neurokinin 1 (NK1) receptors at sites of inflammation. Proc Natl Acad Sci USA 1994; 91:8964-8968.
4. Richardson JD, Vasko MR. Cellular mechanisms of neurogenic inflammation. J Pharmacol Exp Therapeutics 2002; 302:839-845.
5. Geppetti P, Capone JG, Trevisani M, et al. CGRP and migraine: neurogenic inflammation revisited. J Headache Pain 2005; 6:61-70.
6. Leis S, Weber M, Schmelz M, Birklein F. Facilitated neurogenic inflammation in unaffected limbs of patients with complex regional pain syndrome. Neurosci Lett 2004; 359:163-166.
7. Zegarska B, Leliska A, Tyrakowski T. Clinical and experimental aspects of cutaneous neurogenic inflammation. Pharmacol Rep 2006; 58:13-21.
8. Samuels MA. Inflammation and neurological disease. Curr Opin Neurol 2004; 17:307-309.
9. Tracey KJ. The inflammatory reflex. Nature 2002; 420:853-859.
10. Czura CJ, Tracey KJ. Autonomic neural regulation of immunity. J Int Med 2005; 257:156-166.
11. Blalock JE. The immune system as a sensory organ. J Immunol 1984; 132: 1067-1070.
12. Maier SF, Goehler LE, Fleshner M, et al. The role of the vagus nerve in cytokine-to-brain communication. Ann N Y Acad Sci 1998; 840:289-300.
13. Hickey WF. P selectin, pioneer cells and the path to inflammation. Brain 2000; 123:1073-1074.
14. Rothwell NJ (editor). Cytokine in the nervous system. Georgetown, Texas: PG Landes; 1996.
15. Ransohoff RM. The chemokine system in neuroinflamation: an update. J Infect Dis 2002; 186:S152-S156.
16. Streit WJ, Mrak RE, Griffin WST. Microglia and neuroinflammation: a pathological perspective. J Neuroinflamm 2004; 1:1-14.
17. Andreotti F, Porto I, Crea F, et al. Inflammatory gene polymorphisms and ischaemic heart disease: a review of population associated studies. Heart 2002; 87:107-112.
18. Jerrard-Dunne P, Sitzer M, Risley P, et al. Inflammatory gene load is associated with enhanced inflammation and early carotid atherosclerosis in smokers. Stroke 2004; 35:2438-2443.
19. Whitehouse W. Drugs to treat inflammation: a historical introduction. Curr Med Chem 2005; 12:2931-2942.
20. Walter L, Stella N. Cannabinoids and neuroinflmmation: mini review. Br J Pharmacol 2004; 141:775-785.
21. Bernick C, Katz R, Smith NL, et al. Statins and cognitive function in the elderly: the Cardiovascular Health Study. Neurology 2005; 65:1388-1394.